Abstract
The most frequent extra-intestinal manifestation in ulcerative colitis (UC) around the world is joint involvement. There are no previous data in Latin America that is about this aspect of disease; hence, the aim of this study was to determine the frequency and factors associated to joint involvement in Mexican patients with UC. A total of 295 patients with histological diagnosis of UC were studied, divided into two groups: (1) 154 cases with at least one joint affection (arthralgia, peripheral, or axial arthropathy (sacroilitis (SI) or ankylosing spondylitis (AS))) and (2) 141 controls that had never presented any joint involvement during the clinical course of UC. Demographic, clinical, and laboratory variables were collected from the clinical records, at the time of presentation of the joint involvement for the cases and with the last information available for controls. A total of 52.2% of the patients had joint involvement, which was also the most frequent extra-intestinal manifestation (EIM). The frequency of peripheral arthralgia was 46.8% and of axial arthropathy was 5.4% (2.7% AS, 2.4% SI, and 0.3% both). The female gender (P = 0.01, OR = 3.061 95% CI: 1.311–7.15), elevated erythrocyte sedimentation rate (ESR) (P = 0.07, OR = 8.04 95% CI: 1.759–36.764), and moderate disease activity by Truelove and Witts criteria (P = 0.024, OR = 4.37 95% CI: 1.211–15.78) were factors associated at the time of presentation of the joint affection. Joint involvement is the most frequent EIM in Mexican patients with UC. The female gender, elevated ESR, and disease activity are factors associated with its presentation.
Similar content being viewed by others
References
Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361:2066–2078
Rodríguez-Leal GA (2001) Enfermedad Inflamatoria: Epidemiología y Patogénesis. Médica Sur 8:84–89
Yamamoto-Furusho JK (2009) Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006). J Clin Gastroenterol 43:221–224
Bywaters EG, Ansell BM (1958) Arthritis associated with ulcerative colitis: a clinical and pathological study. Ann Rheum Dis 17:169–183
Atzeni F, Defendenti C, Ditto MC et al (2014) Rheumatic manifestations in inflammatory bowel disease. Autoimmun Rev 13:20–23
Pérez-Alamino R, Maldonado-Ficco H, Maldonado-Cocco JA (2016) Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology. Clin Rheumatol 35:291–296
Assche GV, Dignass A, Bokemeyer B et al (2013) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 7:1–33
Danese S, Semeraro S, Papa A et al (2005) Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 11:7227–7236
Barreiro M, Dominguez JE, Nuñez MC et al (2007) Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol 19:73–78
Palm O, Bernklev T, Moum B, Gran JT (2005) Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J Rheumatol 32:1755–1759
Al-Jarallah K, Shehab D, Al-Azmi W, Al-Fadli A (2013) Rheumatic complications of inflammatory bowel diseaseamong Arabs: a hospital-based study in Kuwait. Int J Rheum Dis 16:134–138
Salvarani C, Vlachonnikolis I, Van Der Heijde DM et al (2001) Mucoskeletal manifestations in a population based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–1313
Bourikas LA, Papadakis KA (2009) Musculoskeletal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 15:1915–1924
Leclerc-Jacob S, Lux G, Rat AC et al (2014) The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment Pharmacol Ther 39:957–962
Van Der Heijde D, Sieper J, Maksymowych WP et al (2011) 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 70:905–908
Denmark VK, Mayer L (2013) Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update. Expert Rev Clin Immunol 9:77–92
Atzeni F, Benucci M, Sallì S, Bongiovanni S et al (2013) Different effects of biological drugs in rheumatoid arthritis. Autoimmun Rev 12:575–579
Atzeni F, Talotta R, Benucci M et al (2013) Immunogenicity and autoimmunity during anti-TNF therapy. Autoimmun Rev 12:703–708
Olivieri I, D'angelo S, Padula A et al (2013) Can we reduce the dosage of biologics in spondyloarthritis? Autoimmun Rev 12:691–693
Roberts H, Rai SN, Pan J et al (2014) Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Digestion 90:122–129
Yuksel I, Ataseven H, Basar O et al (2011) Peripheral arthritis in the course of inflammatory bowel diseases. Dig Dis Sci 56:183–187
Alharbi OR, Azzam NA, Almalki AS et al (2014) Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification. World J Gastroenterol 20:17525–17531
Zippi M, Corrado C, Pica R et al (2014) Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 20:17463–17467
Christodoloulou DK, Katsanos KH, Kitsanou M et al (2002) Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis 34:781–786
Arvikar SL, Fisher MC (2011) Inflammatory bowel disease associated arthropathy. Curr Rev Musculoskelet Med 4:123–131
Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–391
Dorofeyev AE, Vasilenko IV, Rassokhina OA (2009) Joint extraintestinal manifestations in ulcerative colitis. Dig Dis 27:502–510
De Vos M (2009) Joint involvement associated with inflammatory bowel disease. Dig Dis 27:511–515
Holden W, Orchard T, Wordsworth P (2003) Enteropathic arthritis. Rheum Dis 29:513–530
Balbir-Gurman A, Schapira D, Nahir M (2001) Arthritis related to ileal pouchitis following total proctocolectomy for UC. Semin Arthritis Rheum 30:242–248
Abi Karam G, Awada H (2003) Ileal pouchitis and arthritis. Semin Arthritis Rheum 33:215
Elia PP, Fogaça HS, Barros RG (2007) Descriptive analysis of the social, clinical, laboratorial and anthropometric profiles of inflammatory bowel disease inwards patients from the “Clementino Fraga Filho” University Hospital, Rio de Janeiro, RJ, Brazil. Arq Gastroenterol 44:332–339
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This work was performed according to the principles expressed in the Declaration of Helsinki. The study was approved by the local ethical committee and a written informed consent was obtained from all patients.
Disclosures
None.
Rights and permissions
About this article
Cite this article
Yamamoto-Furusho, J.K., Sarmiento-Aguilar, A. Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study. Clin Rheumatol 37, 677–682 (2018). https://doi.org/10.1007/s10067-017-3834-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-017-3834-z